Business
Press Release Oct 04 2021
Biocon Limited has informed the Exchange regarding a press release dated October 04, 2021, titled "Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US.".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated October 04, 2021, titled \"Biocon expands its Generic Formulations portfolio with the launch of Everolimus tablets in the US.\". View Attachment","length":369,"tagName":"div"}]